Refining mUltiple Artificial intelliGence strateGies for Automatic Pain Assessment Investigations: RUGGI Study
- Sponsor
- Valentina Cerrone
- Study ID
- NCT07038434
- Status
- Recruiting
Conditions
- Cancer Pain
- Chronic Pain
- Neuropathic Pain
- Pain Assessment
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Multimodal AI-Based Pain Assessment — DIAGNOSTIC_TESTA non-invasive, multimodal diagnostic procedure combining self-reported pain scales (NRS, DN-4, BPI), wearable biosignal acquisition (EDA, EMG, HRV, EEG), facial thermography (HIRA system), video-based facial expression analysis, linguistic interview, and the Stroop Test. Data are used to train and validate machine learning models for automatic pain assessment in chronic pain patients.
Study Details
This single-center, non-profit, observational-interventional study aims to develop artificial intelligence (AI) models for the automatic assessment of chronic pain (APA - Automatic Pain Assessment). The study will enroll adult patients with chronic pain of various origins (oncologic and non-oncologic). Participants will undergo multidimensional evaluations that include clinical assessments, self-report questionnaires, bio-signal collection (e.g., EEG, EDA, HRV, GSR, PPG), and facial expression analysis via infrared thermography and video recordings. The primary objective is to calibrate and test machine learning and deep learning models to recognize and predict the presence and severity of pain using multimodal data inputs. Secondary objectives include evaluating the effectiveness of pain treatments, assessing quality of life, and developing a standardized APA dataset for future research. All data collection procedures are non-invasive and safe, and include tools like wearable sensors and standardized neurocognitive tests. The study is approved by the Italian Ethics Committee (Comitato Etico Territoriale Campania 2) and complies with GDPR and EU AI regulations.
Key Dates
- First listed
- Jun 26, 2025
- Start date
- May 6, 2025
- Status verified
- Jun 2025
- Primary completion
- Dec 31, 2025
- Completion
- Jan 31, 2026
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: AI-Based Pain Assessment in Chronic Pain PatientsParticipants with chronic pain will undergo a multimodal, non-invasive diagnostic assessment including self-reported pain questionnaires (NRS, DN-4, BPI), wearable biosignal acquisition (EEG, EMG, EDA, HRV), facial thermography using the HIRA system, video-based facial expression analysis, linguistic evaluation, and the Stroop Test. These data will be used to develop and validate machine learning models for automatic pain assessment.
Primary Outcome Measure
Accuracy of AI models in classifying chronic pain [ Time Frame: From Day 0 (baseline) to Day 30 (follow-up) ]
Central Contacts
- Marco Cascella, MD, PhD+39 089 672428
- Valentina Cerrone, RN, MSc
Related Studies
- Patient Retrospective Outcomes (PRO)Recruiting · Boston Scientific Corporation · Lake Havasu City, Arizona
- QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory TestingRecruiting · Anna Evans Phillips · Baltimore, Maryland
- Long-Term Real-World Outcomes Study on Patients Implanted With a NeurostimulatorRecruiting · Abbott Medical Devices · Phoenix, Arizona
- PAIN: A Project Assessing the Impact of a Novel Cannabinoid ProductPHASE2 · Recruiting · Staci Gruber, Ph.D. · Belmont, Massachusetts